These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 19065709)

  • 1. Maintaining optimal beta-cell mass for normal metabolism. Proceedings of the Ninth Servier-IGIS Symposium. St Jean Cap Ferrat, France. March 6-9, 2008.
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():1-211. PubMed ID: 19065709
    [No Abstract]   [Full Text] [Related]  

  • 2. Proceedings of the 13th Servier-IGIS Symposium, March 15-18, 2012, St Jean Cap Ferrat, France.
    Diabetes Obes Metab; 2012 Oct; 14 Suppl 3():iv-viii;1-167. PubMed ID: 23346593
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetics of insulin release in health and type 2 diabetes. Proceedings of the 2nd Servier-IGIS Symposium. St. Jean Cap Ferrat, France, 22-24 March 2001.
    Diabetes; 2002 Feb; 51 Suppl 1():S1-283. PubMed ID: 12530425
    [No Abstract]   [Full Text] [Related]  

  • 4. Type 1 and type 2 diabetes: less apart than apparent? Proceedings of the Sixth Servier-IGIS Symposium. March 10-13, 2005. St. Jean Cap Ferrat, France.
    Diabetes; 2005 Dec; 54 Suppl 2():S1-164. PubMed ID: 16306334
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal Models of Islet Dysfunction. Proceedings of the 8th Servier-IGIS Symposium, St Jean Cap Ferrat, France, 8-11 March 2007.
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():1-209. PubMed ID: 18376451
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings of the 14th Servier-IGIS Symposium, 21–24 March 2013, St Jean Cap Ferrat, France.
    Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():4-196. PubMed ID: 24730038
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of insulin production: in search of therapeutic targets. Proceedings of the 3rd Servier-IGIS Symposium. St Jean Cap Ferrrat, France, 21-24 March 2002.
    Diabetes; 2002 Dec; 51 Suppl 3():S285-493. PubMed ID: 12475764
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings of the Neural Orchestration of Metabolism and Islet Function Symposium, March 27-29, 2014, St Jean Cap Ferrat, France.
    Diabetes Obes Metab; 2014 Sep; 16 Suppl 1():1-125. PubMed ID: 26023694
    [No Abstract]   [Full Text] [Related]  

  • 9. Proceedings of the The International Joint Meeting "GEMGERLI - From Membranes to Pathologies", November, 2013, Saint-Jean-Cap-Ferrat, France.
    Biochimie; 2014 Dec; 107 Pt A():1-160. PubMed ID: 26280052
    [No Abstract]   [Full Text] [Related]  

  • 10. The pancreatic beta-cell: birth, life and death.
    Rutter GA; Wong FS
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):267-71. PubMed ID: 18481939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MST1: a promising therapeutic target to restore functional beta cell mass in diabetes.
    Ardestani A; Maedler K
    Diabetologia; 2016 Sep; 59(9):1843-9. PubMed ID: 27053234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anatomical versus functional beta-cell mass in experimental diabetes.
    Kargar C; Ktorza A
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():43-53. PubMed ID: 18834432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of beta-cell dysfunction, ectopic fat accumulation and insulin resistance in the pathogenesis of type 2 diabetes mellitus.
    Gastaldelli A
    Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S60-5. PubMed ID: 21864753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Beta-Cell Function and Mass by the Dual Leucine Zipper Kinase.
    Oetjen E
    Arch Pharm (Weinheim); 2016 Jun; 349(6):410-3. PubMed ID: 27100796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional pancreatic beta-cell mass: involvement in type 2 diabetes and therapeutic intervention.
    Karaca M; Magnan C; Kargar C
    Diabetes Metab; 2009 Apr; 35(2):77-84. PubMed ID: 19251449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta cells in type 2 diabetes - a crucial contribution to pathogenesis.
    Maedler K
    Diabetes Obes Metab; 2008 May; 10(5):408-20. PubMed ID: 17451426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes.
    Donath MY; Böni-Schnetzler M; Ellingsgaard H; Ehses JA
    Physiology (Bethesda); 2009 Dec; 24():325-31. PubMed ID: 19996363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic signaling of insulin secretion by pancreatic β-cell and its derangement in type 2 diabetes.
    Zou CY; Gong Y; Liang J
    Eur Rev Med Pharmacol Sci; 2014; 18(15):2215-27. PubMed ID: 25070829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.